Help kids like Miles race toward more effective osteosarcoma treatments.

Founding Members

Thank you for helping kids like Miles race toward more effective osteosarcoma treatments!
Gold Members

David and Ingrid Hartz
Barbara and Corbin Robertson, Jr.
Mr. and Mrs. Nelson Rusche Foundation
Dan and Megan Tigue

Silver Members

Bedrocks
Sharon and Michael Hartz
Willis and Patsy Johnson
Shawn and Maritza Lafferty

Bronze Members

The Burke Family
Jeff and Sarah Laird
The Harris Family
Lance and Holly Mosby
Bryan and Agatha Pannagl
Tony and Amy Pannagl
The St. John Family
Matt and Kay Kiker

Friends of the Hartz Fund

David Arlott
Jason and Mandi Barrett
Pam and Kevin Ferworn
Dr. Brad Jennings DDS, MDS
Stan and Elizabeth Knight

Richard and Sharon Lansdowne
David and Kyle Lueders
Jason Mathews
Patricia Mustacchia
Scott Shackouls

Stash Houston Logistics
The Cecil Family Fund
Mike and Sonia Woodfall
Thad Woodruff
Peter and Eileen Zwart

 

Miles Hartz’s Story

Miles has always liked extreme sports. His favorite is go-kart racing. He’s also in a fight for his life with osteosarcoma, a pediatric bone cancer.

Over the last four years, Miles has undergone chemotherapy and several surgeries to battle his cancer. Now a high school junior, he continues to receive treatment for osteosarcoma at MD Anderson in Houston, Texas.

We refuse to accept a world where treatment for osteosarcoma is not effective for all patients. A gift to the Osteosarcoma Institute (OSI) supports the most promising clinical trials and science to fight osteosarcoma and keeps kids like Miles on the kart track.

“Miles is my gem, and I would do anything for him. That’s why it is so important to us as a family to support the OSI as it pushes for better treatment options and a cure.” 

David Hartz, Miles’s dad

Osteosarcoma Statistics

bone icon

Osteosarcoma is the most common childhood bone cancer.

microscope icon

No new treatments have been approved for osteosarcoma patients in 40 years.

ribbon icon

1 in 3 children with osteosarcoma will not survive.

Our Partners

What We Do

Our Strategy

Globally estimated, there are over 26,000 new cases of osteosarcoma diagnosed each year, with 1,000 being diagnosed in the US, but treatment options haven’t advanced in 40 years. To find a cure for osteosarcoma, we have to collaborate, innovate, and translate around the most promising science.

Our Mission

The Osteosarcoma Institute’s mission is to dramatically increase treatment options and survival rates in osteosarcoma patients through identifying and funding the most promising and breakthrough osteosarcoma clinical trials and science.

Our Impact

Removing obstacles, funding advancements, accelerating progress, and raising awareness. The Osteosarcoma Institute funds breakthrough clinical trials and science to identify new treatments and, ultimately, a cure for osteosarcoma.

$1,500,000

to Translational Science

$1,300,000

to Clinical Trials

$400,000

to Correlative Research

$128,000

to Patient Support

Real Stories. Real Impact

Parents Raise Osteosarcoma Awareness and Turn Grief into Action

After Jenn and Jonathan Wall lost their 16-year-old son Zach to bone cancer, the experience ignited a passion to provide support to osteosarcoma families.

A Mom Continues Her Daughter’s Fight Against Cancer

After Vicki Bunke lost her 14-year-old daughter, Grace, to osteosarcoma, she started swimming across America to honor her legacy.

Two-time Osteosarcoma Survivor Never Let Cancer Define His Life

Carlos was diagnosed with osteosarcoma when he was 17 and again when he was 20. But, through it all, he never lost his passion for life.

To OSI, No New Options is Not an Option

The Osteosarcoma Institute’s mission is to dramatically increase treatment options and survival rates in osteosarcoma patients through identifying and funding the most promising and breakthrough osteosarcoma clinical trials and science.
Before You Go

Sign-up for our newsletter and stay up-to-date about our fight against Osteosarcoma!

Translate »